Plasma protease inhibitor and anaphylatoxin inactivator levels in chronic urticaria/angioedema and in patients experiencing anaphylactoid reactions to radiographic contrast media

Int Arch Allergy Appl Immunol. 1986;79(2):220-3. doi: 10.1159/000233975.

Abstract

Since a protease inhibitor or anaphylatoxin inactivator deficiency might explain why certain individuals are prone to develop chronic urticaria/angioedema or anaphylactoid reactions to radiographic contrast media, serum alpha 1-protease inhibitor, alpha 1-antichymotrypsin, alpha 2-macroglobulin, inter-alpha-inhibitor, antithrombin III, alpha 2-plasmin inhibitor, C1 inhibitor, and serum carboxypeptidase N were assessed by immunologic or functional methods. These values all were within normal limits in both groups of patients except for a low mean alpha 1-protease inhibitor level in chronic idiopathic urticaria/angioedema and cold urticaria patients and marginal decreases of alpha 1-protease and inter-alpha-inhibitor levels in radiographic contrast medium reactors. However, these abnormalities were not thought to be of pathogenetic significance.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Anaphylatoxins / antagonists & inhibitors*
  • Anaphylaxis / chemically induced*
  • Angioedema / blood*
  • Chronic Disease
  • Contrast Media / adverse effects*
  • Humans
  • Nephelometry and Turbidimetry
  • Peptides / antagonists & inhibitors*
  • Protease Inhibitors / blood*
  • Urticaria / blood*

Substances

  • Anaphylatoxins
  • Contrast Media
  • Peptides
  • Protease Inhibitors